CIK 0000948320
- Accelerated filer
LifeMD, Inc.
Sign in to watch- Ticker
- LFMD
- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 760238453
- Phone
- +1 866-351-5907
- Business address
- 236 FIFTH AVENUE, SUITE 400, NEW YORK, NY, 10001
- Former names
- CONVERSION LABS, INC., Immudyne, Inc.
Securities
- LFMD Common Stock Nasdaq
- LFMDP 8.875% Series A Cumulative Perpetual Preferred Stock Nasdaq
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-09 | Pineiro Dagnery Juan Manuel Former Chief Revenue Officer | Option exercise · Options to purchase Common Stock | −59,421 | 37,900 | ||
| 2021-01-26 | Schreiber Justin Chief Executive Officer | Gift | −20,000 | 3,040,763 | ||
| 2021-01-02 | Walters Happy David Director | Other acquisition | +1,200,000 | 2,107,260 | ||
| 2020-12-31 | Velge Bertrand Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2020-12-09 | Galluppi Stefan Chief Technology Officer | Grant or award | +1,000,000 | 1,749,000 | ||
| 2020-12-09 | Schreiber Justin Chief Executive Officer | Grant or award | +1,000,000 | 3,040,783 | ||
| 2020-12-08 | Alvarez Nicholas P Chief Acquisition Officer | Grant or award · Options to purchase Common Stock | +200,000 | 200,000 | ||
| 2020-11-27 | Alvarez Nicholas P Chief Acquisition Officer | Option exercise | +105,288 | $1.15 | $121K | 109,288 |
| 2020-11-27 | Alvarez Nicholas P Chief Acquisition Officer | Option exercise · Options to purchase Common Stock | −105,288 | 0 | ||
| 2020-10-15 | Walters Happy David Director | Grant or award | +800,000 | 800,000 | ||
| 2020-09-30 | Velge Bertrand Director | Grant or award · Stock Option (Right to Buy) | +2,500 | 2,500 | ||
| 2020-09-23 | Galluppi Stefan Chief Operating Officer | Sale | −401,000 | $1.00 | $401K | 749,000 |
| 2020-09-22 | Velge Bertrand Director | Purchase | +96,923 | $0.65 | $63K | 781,666 |
| 2020-09-22 | Velge Bertrand Director | Grant or award · Warrants to Purchase Common Stock | +100,000 | 100,000 | ||
| 2020-08-18 | Walters Happy David Director | Purchase | +17,773 | $1.28 | $23K | 509,073 |
| 2020-08-18 | Walters Happy David Director | Purchase | +1,000 | $1.26 | $1K | 510,073 |
| 2020-08-18 | Walters Happy David Director | Purchase | +1,200 | $1.29 | $2K | 511,273 |
| 2020-08-18 | Walters Happy David Director | Purchase | +25,027 | $1.30 | $33K | 536,300 |
| 2020-08-17 | Walters Happy David Director | Purchase | +500 | $1.43 | $713 | 426,800 |
| 2020-08-17 | Walters Happy David Director | Purchase | +14,500 | $1.43 | $21K | 441,300 |
Page 12 of 19 · 361 trades